Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

被引:326
作者
Bugianesi, E
Pagotto, U
Manini, R
Vanni, E
Gastaldelli, A
de Iasio, R
Gentilcore, E
Natale, S
Cassader, M
Rizzetto, M
Pasquali, R
Marchesini, G
机构
[1] Univ Turin, Osped San Giovanni Battista, Div Gastroenterol, I-10126 Turin, Italy
[2] Univ Turin, Osped San Giovanni Battista, Dept Internal Med, I-10126 Turin, Italy
[3] Univ Bologna, Dept Internal Med & Gastroenterol, Unit Metab Dis, Bologna, Italy
[4] Univ Bologna, Ctr Appl Biomed Res, Bologna, Italy
[5] Univ Pisa, Dept Internal Med, Pisa, Italy
[6] Univ Pisa, Natl Res Council Inst Clin Physiol, Metab Unit, Pisa, Italy
关键词
D O I
10.1210/jc.2004-2240
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma levels of adiponectin are decreased in patients with nonalcoholic fatty liver disease (NAFLD), but the relationship among plasma adiponectin, insulin sensitivity, and histological features is unclear. In 174 NAFLD patients and 42 controls, we examined plasma adiponectin concentrations in relation to 1) lipid profile, indices of insulin resistance, and features of the metabolic syndrome ( n = 174); 2) hepatic insulin resistance ( clamp technique with tracer infusion) ( 10 patients); and 3) histological features at liver biopsy ( n = 116). When the data from all subjects were combined, plasma adiponectin levels were positively associated with increased age, female gender, and plasma high-density lipoprotein levels, and negatively associated with waist circumference, body mass index, triglycerides, indices of insulin resistance, and aminotransferase levels, and also predicted the presence of the metabolic syndrome. In step-wise regression, increased age, female gender, waist circumference, triglyceride levels, and homeostasis model assessment independently associated with adiponectin ( adjusted R-2, 0.329). In NAFLD, adiponectin was only associated with increased age, female gender, and triglycerides ( adjusted R-2, 0.245). When the measured histological parameters were included in the model, plasma adiponectin levels were also inversely proportional to the percentage of hepatic fat content ( adjusted R2, 0.221), whereas necroinflammation and fibrosis did not fit in the model. Adiponectin was negatively correlated with insulin-suppressed endogenous glucose production during the clamp ( P = 0.011). The results demonstrate that decreased levels of circulating adiponectin in NAFLD are related to hepatic insulin sensitivity and to the amount of hepatic fat content. Hypoadiponectinemia in NAFLD is part of a metabolic disturbance characterized by ectopic fat accumulation in the central compartment.
引用
收藏
页码:3498 / 3504
页数:7
相关论文
共 47 条
  • [1] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [2] 2-S
  • [3] Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients
    Bajaj, M
    Suraamornkul, S
    Piper, P
    Hardies, LJ
    Glass, L
    Cersosimo, E
    Pratipanawatr, T
    Miyazaki, Y
    Defronzo, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 200 - 206
  • [4] Adiponectin relationship with lipid metabolism is independent of body fat mass:: Evidence from both cross-sectional and intervention studies
    Baratta, R
    Amato, S
    Degano, C
    Farina, MG
    Patanè, G
    Vigneri, R
    Frittitta, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2665 - 2671
  • [5] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [6] Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
    Brunt, EM
    Janney, CG
    Di Bisceglie, AM
    Neuschwander-Tetri, BA
    Bacon, BR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) : 2467 - 2474
  • [7] Relative contribution of iron burden, HFE mutation and insulin resistance to fibrosis in nonalcoholic fatty liver
    Bugianesi, E
    Manzini, P
    D'Antico, S
    Vanni, E
    Longo, F
    Leone, N
    Massarenti, P
    Piga, A
    Marchesini, G
    Rizzetto, M
    [J]. HEPATOLOGY, 2004, 39 (01) : 179 - 187
  • [8] Quantification of gluconeogenesis in cirrhosis: Response to glucagon
    Bugianesi, E
    Kalhan, S
    Burkett, E
    Marchesini, G
    McCullough, A
    [J]. GASTROENTEROLOGY, 1998, 115 (06) : 1530 - 1540
  • [9] Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI 10.1111/j.1572-0241.2003.07486.x
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497